Symphonic Capital Closes $13.5M Fund Focused on Health and Wealth Equity

Symphonic Capital, a new early-stage venture capital firm founded by Sydney Thomas, announced the close of its $13.5 million debut fund aimed at advancing equity in healthcare and financial services.

The fund will invest in startups led by founders working to close access gaps for underserved and overlooked communities. Symphonic Capital targets companies at the earliest stages—those with a minimum viable product and valuations under $10 million—particularly those located outside traditional tech hubs such as San Francisco and New York.

“We’re excited to announce the launch of our first fund and deeply honored to have the backing of an incredible group of like-minded partners,” Thomas said in a statement. “We believe in the vision we’re building at Symphonic and look forward to putting our thesis to work: investing in founders committed to creating a more equitable future for all.”

As part of the launch, Shruti Shah joined the firm as a partner. Shah, an entrepreneur and operator, will help lead investments and portfolio support across healthcare and financial technology sectors.

“Our first fund prioritizes companies addressing inequities in healthcare and financial services because we recognize the opportunity to create outsized impact in communities that have long been overlooked and underserved,” Shah said.

Before launching Symphonic Capital in 2022, Thomas was the first hire at Precursor Ventures, where she led investments into companies including Teal Health, Guava, and Mira. The new fund marks her transition to leading her own firm with a focused investment thesis centered on inclusion and long-term value creation.

Symphonic Capital joins a small but growing group of Black-led venture firms working to diversify the flow of capital in the startup ecosystem. The firm plans to make initial investments in 20 to 25 companies from the debut fund.

For more news like this, subscribe to the SBLK Ventures Newsletter.